KingMed Diagnostics Turns Profitable in H1 2026, Net Profit RMB190 Million
KingMed Diagnostics reported a net profit of RMB190 million for the first half of 2026, swinging from a loss of RMB84.81 million in the same period of 2025. Revenue declined 3.76% year on year to RMB2.884 billion. Basic earnings per share were RMB0.41. The company released its interim report for 2026.
KingMed Diagnostics disclosed its interim report for 2026. In the first half of 2026, the company achieved operating revenue of RMB2.884 billion, down 3.76% year on year. Net profit attributable to shareholders of the listed company was RMB190 million, compared with a loss of RMB84.81 million in the same period of 2025, marking a turnaround to profitability. Basic earnings per share were RMB0.41.